Allied Market Research


Biopharma Cold Chain Packaging Market

Biopharma Cold Chain Packaging Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, by Application and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Biopharma cold chain product is defined as any temperature-sensitive substance, such as frozen foods, blood components, stem cells, tissues, cells, vaccines, and infectious substances, which involves safe packaging to endure cold temperatures of the storage containers during transportation. Secure packaging ensures the sterility, safety, and viability of the biopharma products and specimen inside. 

Cold chain packaging uses active and passive packaging methods. Active packaging comprises leased containers that employ a power source and a thermostat to control heating or cooling inside the shipping container. Conversely, passive packaging configurations are manufactured containers that utilize insulated packaging such as polyurethane, polystyrene, or vacuum insulated panels and phase change materials (PCM) to sustain a desired temperature within the shipping container.

COVID-19 Impact Analysis

  • The COVID-19 pandemic disturbed the entire supply chain in the majority of industries across the globe. However, cold chain packaging was considered an essential service by regulatory bodies across the globe. The role of the cold chain became more important during the pandemic, as the demand for medicines, vaccines, blood components, and food products was increasing at an alarming rate. Essential precautions have been taken by regional and global cold chain associations to combat the situation incurred by theCOVID-19.
  • For instance, the Global Cold Chain Alliance (GCCA) is prescribing the mandatory actions to speed up the recovery of the industry. The GCCA is continuously updating guidelines as per the instructions from the regional government.

Top Impacting Factors

Changing lifestyle of people, growing population, and rapid urbanization in emerging economies are triggering consumers to opt for processed and easy-to-eat food items. The requirement for efficient packaging and transportation solutions in the biopharmaceutical industries primarily drives the biopharma cold chain packaging market growth.

Stringent government regulations (mandate the use of high barrier packaging materials and sealants for several liquid drugs) for the packaging of biopharma products are impacting the market positively. 
Governments in developing countries are continuously upgrading their industry standards for packaging to maintain quality, safety, and to reduce breakage/spillage and contamination. This trend is likely to boost the demand for the advanced biopharma chain packaging market.

An increase in the development of more complex biological-based medicines and shipments of vaccines, hormone treatments, and complex proteins that require cold chain refinements to be transported at a controlled temperature has increased the demand for biopharma cold chain packaging market.
However, high cost associated with cold chain packaging is expected to restrain the biopharma cold chain packaging market growth.

Market Trends

New product launches to flourish the market

  • In February 2020, Pelican BioThermal acquired NanoCool to expansd its BioThermal product portfolio. The addition of the latter’s customers, product technologies, and segments would enable Pelican to broaden its access to last-mile players, laboratories, and patients.
  • September 2020 - Sonoco ThermoSafe released its new Pegasus ULD bulk temperature-controlled container, which is one of the world’s first passive bulk temperature-controlled container for pharmaceutical use that is an FAA-approved unit load device. It allows it to speed through existing international ground handling and customs processes at the lowest possible cost.
  • June 2020 - Softbox launched ECO packaging solution Tempcell ECO, which is a new curbside-recyclable temperature control parcel shipper for the pharma cold chain industry. It is made from 100% corrugated cardboard and utilizes the company's Thermaflute patent-pending plastic-free insulation technology. The product's cardboard is used to create effective insulation layers that offers thermal efficiencies similar to those of traditional expanded polystyrene shippers, while being easily and globally recyclable.

Surge in usage to pack temperature-sensitive pharmaceutical products

  • Various cold chain packaging products are extensively used to pack temperature-sensitive pharmaceutical products and ingredients, owing to the fact that the products or drugs many times lose their properties when exposed to high temperatures. For their functional and chemical values to be preserved, they require particular temperature-controlled transportation techniques and packaging. These factors are expected to surge the biopharma cold chain packaging market growth during the forecast period.

Key Benefits of the Report

  • This study presents the analytical depiction of the biopharma cold chain packaging along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the biopharma cold chain packaging market share.
  • The current market is quantitatively analyzed to highlight the biopharma cold chain packaging market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed biopharma cold chain packaging market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Biopharma Cold Chain Packaging Report

  • Who are the leading market players active in the biopharma cold chain packaging market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "biopharma cold chain packaging "?
  • What is "biopharma cold chain packaging " market prediction in the future?
  • Who are the leading global players in the "biopharma cold chain packaging " market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "biopharma cold chain packaging " market report?

Biopharma Cold Chain Packaging Market Report Highlights

Aspects Details
By Product Type
  • Refringent
  • Insulated Container
  • Temperature Monitoring
By Application
  • Food
  • Dairy
  • Pharmaceutical
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players

Sonoco ThermoSafe, Sofrigam, Creopack, Cryopak A TCP Company, va-Q-tec., Softbox systems, Cascades Inc, Cold Chain Technologies, Intelsius, Pelican Products, Inc

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Biopharma Cold Chain Packaging Market

Global Opportunity Analysis and Industry Forecast, 2023-2032